Study Protocol
Published on 08 May 2026
Efficacy and safety of Shenqi Yangxin formula in patients with stable coronary artery disease based on CCTA: rationale, design, and study protocol for a randomized, double-blind, placebo-controlled study
in Coronary Artery Disease
- 388 views